NVST Stock Analysis: Buy, Sell, or Hold?

NVST - Envista Holdings Corporation Common stock, $0.01 par value per share

DENTAL EQUIPMENT & SUPPLIES
$26.78
0.67 (2.57%) ▲
5d: +4.04%
30d: +8.86%
90d: -2.19%
BUY
MODERATE Confidence
Analysis Updated: Jul 14, 2026 12:00 AM ET
Earnings: Aug 05, 2026 20d
Smart Money Accumulation

None View Scanner →

Strength: 4.5/10

Get Alerted When NVST Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
💡 BUY OPPORTUNITY: NVST shows positive signals but monitor for confirmation. Market pricing in 0.8% decline. Moderate conviction.
See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$37.39
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$23.21
Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 17.0x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: NVST is currently trading at $26.78, which is considered fair relative to its 30-day fair value range of $24.47 to $26.88. The stock's valuation (Forward PE: 16.6) is in line with its historical norms (17.0). Remarkably, the market is currently pricing in an annual earnings decline of 0.8% over the next few years. This pessimistic expectation contrasts with the company's recent 130.0% earnings growth, suggesting potential undervaluation if the company simply maintains stability.

Technical Outlook: Technically, NVST is in a strong uptrend. Immediate support is located at $25.22, while resistance sits at $27.90.

Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $29.43 (+12.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position FAIR
Historical Trading Range $24.47 - $26.88
Company Quality Score 54/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 70.0%

All Signals

  • NEUTRAL: Price in fair range
  • NEUTRAL: Mixed technical signals (40/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading below Wall St target ($29.43)

Trading Range Analysis

30-Day Trading Range $24.47 - $26.88
Current vs Trading Range FAIR

Support & Resistance Levels

Support Level $25.22
Resistance Level $27.90
Current Trend Strong Uptrend
Technical data as of Jul 14, 2026

Fundamental Context

Forward P/E (Next Year Est.) 16.60
Wall Street Target $29.43 (+12.7%)
Revenue Growth (YoY) 14.4%
Earnings Growth (YoY) 130.0%
Profit Margin 2.4%
Valuation Discount vs History -0.8% cheaper
PE vs Historical 16.6 vs 17.0 FAIR
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): -0.8% (market-implied from PE analysis)
1-Year Target $25.90 (-1%)
2-Year Target $25.69 (-2%)
3-Year Target $25.49 (-2%)
3-Yr Target (if PE normalizes) (PE: 17→17) $26.11 (0%)
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 21.8, Growth: 9.9%) $45.42 (+74%)
Base: (SPY PE: 16.6, Growth: 9.9%) $34.61 (+33%)
Bear: (PE: 14.1, Growth: 9.9%) $29.42 (+13%)
📈 Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (20x PE), but valuation improves significantly next year (17x PE) as earnings recover.
Forward PE: 20.33 | Forward EPS (Implied): $1.28
Bull Case $31.53 (+21%)
Analyst growth 15.0%, PE expands to 21.3
Base Case $26.11 (0%)
Market implied 0.0%, PE stable at 20.3
Bear Case $19.97 (-24%)
Severe decline -15.0%, PE contracts to 18.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡 Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 16.6 to 17.0
Stabilization Target: $26.74 (+2.4%)
PE Expansion Potential: +2.4%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: July 15, 2026 9:56 AM ET
Data refreshes hourly during market hours. Next update: 10:56 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Mischa Reis SELL 9675 shares 2026-02-10

Unlock Insider Activity

See real-time buying/selling by company executives for NVST.

Create Free Account

Already have an account? Log In

Top Rated Medical Instruments & Supplies Stocks

Top-rated stocks in Medical Instruments & Supplies by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ALC
Alcon AG
STRONG BUY
27 analysts
$88 64 BUY
ISRG
Intuitive Surgical Inc
BUY
33 analysts
$562 45 HOLD
RGEN
Repligen Corporation
STRONG BUY
19 analysts
$177 56 HOLD
WST
West Pharmaceutical Serv…
STRONG BUY
13 analysts
$366 63 BUY
RMD
ResMed Inc
BUY
19 analysts
$256 50 HOLD

Advanced NVST Option Strategies

Professional options setups generated by AI based on today's NVST price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for NVST

NVST Technical Chart NVST Price Prediction NVST Earnings Date NVST Investment Advisor NVST Fair Price Analyzer NVST Options Advisor NVST Options Chain NVST Options Analysis NVST Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals